...
首页> 外文期刊>Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis >Rapid onset heparin-induced thrombocytopenia (HIT) without history of heparin exposure: A new case of so-called 'spontaneous' HIT
【24h】

Rapid onset heparin-induced thrombocytopenia (HIT) without history of heparin exposure: A new case of so-called 'spontaneous' HIT

机译:没有肝素暴露史的肝素诱导的血小板减少症(HIT)的快速发作:所谓的“自发性” HIT的新病例

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Heparin-induced thrombocytopenia (HIT) is a life-threatening adverse effect of heparin therapy, resulting from the formation of heparin-dependent and platelet-activating antibodies favouring hy-percoagulability and promoting thrombosis (1). Although the understanding of the pathogenesis of the syndrome has much increased, many unresolved questions remain, more particularly dealing with exceptional situations where the typical delay of occurrence of HIT (5-20 days after starting heparin therapy) is not present, such as delayed-onset HIT described in early 2000. More recently, few cases of another very atypical HIT-related situation have been reported, challenging the conventional understanding of the syndrome, the so-called 'spontaneous HIT', occurring in patients who have never been exposed with heparin (2-4).
机译:肝素诱导的血小板减少症(HIT)是肝素治疗危及生命的不良反应,是由于形成了肝素依赖性和血小板活化抗体,有利于高血凝性并促进血栓形成(1)。尽管对这种综合征发病机理的了解已大大增加,但仍有许多悬而未决的问题,尤其是在不存在典型的HIT发生延迟(开始肝素治疗后5-20天)的特殊情况下,例如延迟-在2000年初就描述了HIT发作。最近,又有极少数非典型HIT相关情况的报道,这挑战了对这种综合征的传统认识,即所谓的“自发性HIT”,发生在从未接触过HIT的患者中。肝素(2-4)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号